These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3108397)
21. Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment. Dupré ; Herv M; Schacht AM; Capron A; Riveau G J Infect Dis; 1999 Aug; 180(2):454-63. PubMed ID: 10395862 [TBL] [Abstract][Full Text] [Related]
22. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223 [TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Allam G Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123 [TBL] [Abstract][Full Text] [Related]
25. Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite death. Pica-Mattoccia L; Orsini T; Basso A; Festucci A; Liberti P; Guidi A; Marcatto-Maggi AL; Nobre-Santana S; Troiani AR; Cioli D; Valle C Exp Parasitol; 2008 Jul; 119(3):332-5. PubMed ID: 18456260 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of specific antibody binding to adult male Schistosoma mansoni by adsorbed host serum components. Rasmussen KR; Kemp WM J Parasitol; 1985 Oct; 71(5):530-4. PubMed ID: 4056998 [TBL] [Abstract][Full Text] [Related]
27. Altered immunoglobulin isotype profile and anti-immature worm surface immunoglobulins in mice harboring a praziquantel-resistant Schistosoma mansoni isolate. Hanallah S; El-Lakkany N; Mahmoud S; Mousa M; Botros S APMIS; 2003 Dec; 111(12):1125-32. PubMed ID: 14678022 [TBL] [Abstract][Full Text] [Related]
28. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel. Fallon PG; Doenhoff MJ Parasite Immunol; 1995 May; 17(5):261-8. PubMed ID: 7675513 [TBL] [Abstract][Full Text] [Related]
29. Schistosoma mansoni: immunoreactivity of human sera with the surface antigen Sm23. Köster B; Hall MR; Strand M Exp Parasitol; 1993 Nov; 77(3):282-94. PubMed ID: 8224084 [TBL] [Abstract][Full Text] [Related]
30. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates. Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853 [TBL] [Abstract][Full Text] [Related]
31. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni. Allam G; Eweas AF; Abuelsaad AS Parasitol Res; 2013 Sep; 112(9):3137-49. PubMed ID: 23793335 [TBL] [Abstract][Full Text] [Related]
32. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni. Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522 [TBL] [Abstract][Full Text] [Related]
33. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice. Giboda M; Smith JM J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010 [TBL] [Abstract][Full Text] [Related]
34. In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance. Kelly EA; Colley DG J Immunol; 1988 Apr; 140(8):2737-45. PubMed ID: 3128606 [TBL] [Abstract][Full Text] [Related]
35. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. El Ridi R; Tallima H Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448 [TBL] [Abstract][Full Text] [Related]
36. The immune-dependence of schistosomicidal chemotherapy: relative lack of efficacy of an antimonial in Schistosoma mansoni-infected mice deprived of their T-cells and the demonstration of drug-antiserum synergy. Doenhoff MJ; Bain J Clin Exp Immunol; 1978 Aug; 33(2):232-8. PubMed ID: 309809 [TBL] [Abstract][Full Text] [Related]
37. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections. Don TA; Bethony JM; Loukas A Int J Infect Dis; 2008 Nov; 12(6):e39-47. PubMed ID: 18571965 [TBL] [Abstract][Full Text] [Related]
38. Prolonged somatostatin therapy may cause down-regulation of SSTR-like GPCRs on Schistosoma mansoni. Chatterjee S; Op De Beeck J; Rao AV; Desai DV; Vrolix G; Rylant F; Panis T; Bernat A; Van Bergen J; Peeters D; Van Marck E J Vector Borne Dis; 2007 Sep; 44(3):164-80. PubMed ID: 17896619 [TBL] [Abstract][Full Text] [Related]
39. Immunostimulatory effect of coumarin derivatives before and after infection of mice with the parasite Schistosoma mansoni. Maghraby A; Bahgat M Arzneimittelforschung; 2004; 54(9):545-50. PubMed ID: 15500201 [TBL] [Abstract][Full Text] [Related]
40. Artemether as adjuvant therapy to praziquantel in murine Egyptian schistosomiasis mansoni. Mahmoud MR; Botros SS J Parasitol; 2005 Feb; 91(1):175-8. PubMed ID: 15856895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]